Schrödinger, Inc.
We're Hiring!
Schrödinger, Inc. Leadership & Management
What People Are Saying About Schrödinger, Inc.
-
Strategic Vision & Planning: Leadership repeatedly sets a clear direction centered on scaling the physics+AI platform and a dual software‑plus‑therapeutics model. The 2026 focus areas and longer‑term 2028 objectives provide a coherent roadmap.
-
Purposeful Goal Setting: Management links strategy to dated milestones and financial guardrails, including 2026 ACV and drug‑discovery targets, quarterly ACV checkpoints, and 2028 profitability aims. Named deliverables like predictive toxicology beta and early‑access for Bunsen offer tangible near‑term waypoints.
-
Open & Transparent Communication: Communications explicitly flag tradeoffs and dependencies—such as near‑term GAAP revenue pressure from the hosted transition, clinical and partner uncertainties, and adoption risk for new AI workflows. Guidance reaffirmations and explanations of metric mix (ACV vs. revenue) further clarify expectations.
Schrödinger, Inc.'s Benefits
Implements team-based strategic planning
Uses an OKR operational model to clearly define goals and priorities
Utilizes an open door policy that encourages accessibility
